The ExaStim neurostimulator received FDA breakthrough device designation ... and sensation” in patients with chronic tetraplegia due to cervical SCI. September: Nevro earned FDA approval and began a ...

NEW YORK, NY / ACCESS Newswire / April 16, 2025 / Nevro Corp., recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of individuals.

It has been about a month since the last earnings report for Nevro (NVRO). Shares have added about 0.9% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...

StockNews.com began coverage on shares of Nevro (NYSE:NVRO – Free Report) in a report published on Saturday morning. The brokerage issued a hold rating on the medical equipment provider’s stock.

NEW YORK, NY / ACCESS Newswire / April 17, 2025 / Nevro Corp., recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of individuals ...

Globus Medical, Inc. GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers comprehensive, life-changing solutions for the ...

AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition ...

REDWOOD CITY, CA – Nevro Corp , a medical device company with annual revenues of $408.52 million and a market capitalization of $221.21 million, announced on Monday that it has completed a merger with ...

Nevro is a medical device company headquartered in Redwood City, California. If you received a data breach notice letter and wish to discuss this action, obtain further information, and/or ...